Anticoagulant Market, By Drug Class (Novel Oral Anticoagulants (NOACs), Heparin and Low-molecular- weight Heparin(LMWH), and Vitamin K Antagonist), By Application (Atrial Fibrillation/Myocardial Infarction (Heart Attack), Deep Vein Thrombosis (DVT), Pulmonary Embolism, and Other Applications), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Published In : Jan 2023

Code : CMI5486

Pages :169

Formats :

Excel and PDF

Industry : Pharmaceutical

Market Challenges And Opportunities

However, factors such as side effects associated with anticoagulants and stringent government regulations are expected to hamper growth of the global anticoagulant market.

Global Anticoagulant Market Drivers:

Growing prevalence of chronic diseases across the globe is expected to boost the growth of global anticoagulant market during the forecast period. For instance, direct oral anticoagulants (DOACs) are used to prevent and treat cardiovascular disease. DOACs are anticoagulation pharmacotherapy used for the prevention of thrombosis in several cardiovascular contexts. According to the World Health Organization (WHO), cardiovascular diseases (CVDs) are the leading cause of death across the world, taking an estimated 17.9 million lives each year. This in turn is expected to increase the demand for anticoagulants around the world.

Increase in demand for anticoagulants around the world is expected to propel growth of the global anticoagulant market during the forecast period. For instance, in December 2020, Natco Pharma announced the launch of an anti-blood clot tablet, named Rivaroxaban, to treat and prevent blood clots. Rivaroxaban is currently sold by Bayer under brand name of Xarelto in the Indian market. Natco has launched RPIGAT in four strengths, 20 mg, 15 mg, 10 mg, and 2.5 mg. The novel oral anti-coagulant, Rivaroxaban, is in line with Natco’s mission of affordable medicines accessible to all, a release from Natco Pharma said.

Global Anticoagulant Market Restraints:

Side effects associated with some anticoagulant are expected to hamper the growth of the global anticoagulant market. For instance, anticoagulant medications can cause side effects that may lead to more serious complications. The most common side effect associated with any anticoagulant is bleeding. Depending on the medicine used, other potential risks exist. They can also cause nausea, upset stomach, and diarrhea, among others.

Stringent government regulations are expected to hinder growth of the anticoagulant market. The usage of oral anticoagulants is being monitored for adverse drug events. For instance, the United States Food Drug Administration (FDA) uses standard surveillance definitions for anticoagulant-related bleeding events in post-marketing and/or epidemiologic analyses, to access the accuracy of diagnostic and procedural coding to capture anticoagulant-related bleeding events.